Earlier this year Ethical Partners Investment Director Nathan Parkin spoke at the Elevate Modern Slavery Conference, which included industry, government, NGO and academic speakers and delegates. Nathan spoke on the importance of the investor voice in addressing the Modern Slavery Issue and about the research Ethical Partners has conducted into the supply chain and human rights disclosures of the top 220 companies listed on the ASX. This research showed that only 4/10 companies even mentioned supply chain or human rights in their reporting. He also encouraged the companies present to be willing to look for and address the issue of modern slavery better in their business practices and reporting and be honest about what they find and how they plan to fix it.
Nathan then discussed the importance of investors rewarding companies for doing this, which we hope will make companies feel more comfortable to examine their supply chains honestly. Ethical Partners also feels strongly that companies looking at, and fixing their supply chains, will help to reduce their reputational and business risks, thus benefitting both those affected by modern slavery and shareholders. We look forward to being involved in many more of these collaborative and advocacy events in the future.
During October 2021 the Fund returned 1.09% versus the S&P/ASX 300 Accumulation Index of 0.10%, outperforming the market by 0.99%. An overweight position in Materials added to relative performance while and overweight position in Financials detracted from relative performance.
This World Children’s Day, 20 November, we recognise the devastating and disproportionate impact the climate crisis is having and will continue to have on children. As the most anticipated event of the year, COP26, finishes, it remains clear we have never needed more urgent action from government, business and society to respond to the climate crisis
During September 2021 the Fund returned -1.19% (after fees) versus the S&P/ASX 300 Accumulation Index of -1.89%, outperforming the market by 0.70%. An underweight position in Healthcare and an overweight position in Transport added to relative performance. Over the last 12 months the Fund has returned 36.03%, outperforming the ASX300 Accum Index by 5.17%.